Published by
@ShahidNShah
@ShahidNShah
Using MolecuLight i:MolecuLight i:X ™ for wound assessment with clinical signs and symptoms allows clinicians to safely and easily identify more wounds containing elevated bacterial burden (104 CFUg), and measure wounds at the point-of-care.MolecuLight i:MolecuLight i:X ™ provides information at the patient bedside to improve current evaluation by CSS. Using MolecuLight i:MolecuLight i:X ™, identifies more wounds with elevated bacterial load compared to clinical signs and symptoms alone enabling more efficient patient management.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Mar 3, 2025 at 6:28am